Cubist Systematic Strategies’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Cubist Systematic Strategies’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-59,557	Closed	-$2.77M	–	4201
2023 Q2	$2.77M	Buy	+59,557	New	+$2.06M	0.02%	1252
2022 Q2	–	Sell	-5,035	Closed	-$96K	–	4678
2022 Q1	$96K	Sell	5,035 -9,235	-65%	-$165K	﹤0.01%	3261
2021 Q4	$361K	Buy	+14,270	New	+$418K	﹤0.01%	2669

Cubist Systematic Strategies's DICE Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 59,557 shares — an estimated $2.77M sold.

Cubist Systematic Strategies first reported a position in DICE in Q4 2021 and held it in 3 quarters. The position peaked at $2.77M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Cubist Systematic Strategies reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 59,557 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.77M.
Cubist Systematic Strategies first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
Cubist Systematic Strategies's DICE Therapeutics, Inc. Common Stock position peaked at $2.77M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.